Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Aakaar Medical Technologies Ltd
Quarter-by-quarter operating performance
Financials of Aakaar Medical Technologies Ltd
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | 66.96 |
| Expenses + | 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.84 | 56.64 |
| Operating Profit | 2.88 | 0.90 | 2.40 | 3.53 | 5.00 | 9.74 | 10.32 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.82% | 15.41% |
| Other Income + | 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | 0.80 |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 | 1.80 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 | 0.13 |
| Profit before tax | 2.50 | 0.76 | 2.21 | 3.10 | 3.88 | 8.09 | 9.19 |
| Tax % | 26.80% | 28.95% | 26.24% | 30.65% | 26.29% | 25.22% | 27.86% |
| Net Profit + | 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.04 | 6.64 |
| EPS in Rs | 183.00 | 54.00 | 23.14 | 30.71 | 41.00 | 5.80 | 4.69 |
| Dividend Payout % | 0.00% | 0.00% | 34.57% | 24.42% | 0.00% | 0.00% | 0.00% |
Financials of Aakaar Medical Technologies Ltd
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.70 | 0.70 | 0.70 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.30 | 7.33 | 8.96 | 11.84 | 12.78 | 40.38 |
| Borrowings + | 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 18.53 |
| Other Liabilities + | 3.56 | 3.03 | 6.15 | 7.70 | 6.42 | 8.17 | 6.34 |
| Total Liabilities | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 79.42 |
| Fixed Assets + | 0.06 | 0.04 | 0.20 | 0.36 | 0.28 | 0.24 | 0.69 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.47 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets + | 15.76 | 14.16 | 17.80 | 22.87 | 33.73 | 53.87 | 78.73 |
| Total Assets | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 79.42 |
Financials of Aakaar Medical Technologies Ltd
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | -8.36 |
| Cash from Investing Activity + | 0.10 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | 0.05 |
| Cash from Financing Activity + | 0.28 | -2.00 | -0.81 | 1.17 | 8.19 | 10.71 | 18.80 |
| Net Cash Flow | 0.00 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 | 10.48 |
| Free Cash Flow | -0.40 | 4.30 | 0.29 | -3.19 | -8.09 | -5.49 | -8.94 |
| CFO/OP | 10% | 503% | 47% | -54% | -136% | -35% | -59% |
Financials of Aakaar Medical Technologies Ltd
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 | 202.94 |
| Inventory Days | 234.33 | 366.16 | 281.70 | 273.75 | 247.29 | 202.47 | 255.63 |
| Days Payable | 28.20 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 | 24.33 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.10 | 344.26 | 319.59 | 434.24 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.85 | 198.91 |
| ROCE % | 8.25% | 20.93% | 25.79% | 23.28% | 26.66% | 18.47% |
Quick commerce channel is rapidly growing, currently about 10% of revenues, with healthy economics and fastest-growing channel. Key concall takeaways from…
The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues. Key…
Recent quarters saw exponential growth: 20% YoY in FY26 and 28% YoY in Q1 FY27, partly due to prior price corrections and strategic actions (Nishita Shanklesha…
Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium…